Description
Anti-inflammatory, insecticidal, and anticancer tetrahydrobenzofuran isolated from Aglaia species that inhibits TNF-α, NF-κB, NF-AT and various cytokines (IFN-γ, TNF-α, IL-2, and IL-4) with IC50 values in the nanomolar range; induces apoptosis in human leukemia cell lines, activating p38 MAPK/JNK and suppressing ERK
Formal name: (1R,2R,3S,3aR,8bS)-2,3,3a,8b-tetrahydro-1,8b-dihydroxy-6,8-dimethoxy-3a-(4-methoxyphenyl)-N,N-dimethyl-3-phenyl-1H-cyclopenta[b]benzofuran-2-carboxamide
Synonyms: NSC 326408|Roc-A|Rocaglamide A
Molecular weight: 505.6
CAS: 84573-16-0
Purity: ≥95%
Formulation: A crystalline solid
Product Type|Biochemicals|Natural Products||Product Type|Biochemicals|Pesticides|Insecticides||Product Type|Biochemicals|Small Molecule Inhibitors|TNF-α/NF-κB Signaling||Research Area|Cancer|Cell Death|Apoptosis||Research Area|Cancer|Cell Signaling|ERK/MAPK Signaling||Research Area|Cancer|Cell Signaling|NF-κB Signaling||Research Area|Cancer|Cell Signaling|p38 MAPK Signaling||Research Area|Cancer|Transcription Factors|NF-κB||Research Area|Cell Biology|Cell Signaling|NF-κB Signaling||Research Area|Epigenetics, Transcription, & Translation|Transcription Factors||Research Area|Immunology & Inflammation|Adaptive Immunity